---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-035033"
form_type: "8-K"
ticker: "WINT"
cik: "0000946486"
company_name: "WINDTREE THERAPEUTICS INC /DE/"
filed_at: "2024-11-14T23:59:59+00:00"
generated_at: "2026-05-30T00:43:32.043183+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Windtree CEO Craig Fraser retires; Jed Latkin appointed President & CEO effective Dec 1, 2024

## Summary
- Craig Fraser retires as President and CEO effective Dec 1, 2024, but remains Chairman of the Board.
- Jed Latkin, age 50, appointed President and CEO; previously COO and CFO of ProPhase Labs.
- Latkin's base salary set at $557,300, with target annual bonus of 50% of base salary.
- Latkin eligible for equity award of 2.5% of outstanding shares, subject to shareholder approval.
- Employment agreement includes 12-month non-compete and severance benefits for termination without cause or change in control.

## SEC filing metadata
- accession: 0001437749-24-035033
- form_type: 8-K
- ticker: WINT
- cik: 0000946486
- company_name: WINDTREE THERAPEUTICS INC /DE/
- filed_at: 2024-11-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946486/000143774924035033/0001437749-24-035033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946486/000143774924035033/wint20241113_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-035033
- JSON: https://secwatch.observer/filing/0001437749-24-035033.json
- Plain text: https://secwatch.observer/filing/0001437749-24-035033.txt

## Key facts
- Executive change
  Craig Fraser retired as President and Chief Executive Officer at WINDTREE THERAPEUTICS INC /DE/.
  - Action: retired
  - Role: President and Chief Executive Officer
  source text: Craig Fraser will retire as the Company’s President and Chief Executive Officer, effective as of December 1, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/946486/000143774924035033/0001437749-24-035033-index.htm
- Executive change
  Jed Latkin was appointed as President and Chief Executive Officer at WINDTREE THERAPEUTICS INC /DE/.
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: the Company announced the appointment of Jed Latkin, age 50, a current member of the Board, to serve as the Company’s President and Chief Executive Officer, effective as of the Transition Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/946486/000143774924035033/0001437749-24-035033-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.